Novasep is a CDMO specialized in the production and purification of biologics, offering global and integrated services from development to clinical & commercial manufacturing.

For 20 years, Novasep has developed and manufactured numerous viral vectors (lentivirus, AAV, adenovirus, HSV…) for cell & gene therapy, oncology, vaccination and other therapies.